| CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 1052 | 2013 |
| Human natural Treg microRNA signature: role of microRNA‐31 and microRNA‐21 in FOXP3 expression R Rouas, H Fayyad‐Kazan, N El Zein, P Lewalle, F Rothé, A Simion, ... European journal of immunology 39 (6), 1608-1618, 2009 | 348 | 2009 |
| Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis Y Bareche, D Venet, M Ignatiadis, P Aftimos, M Piccart, F Rothe, ... Annals of oncology 29 (4), 895-902, 2018 | 333 | 2018 |
| Genomic characterization of primary invasive lobular breast cancer C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ... Journal of clinical oncology 34 (16), 1872-1881, 2016 | 311 | 2016 |
| Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ... PloS one 6 (6), e20980, 2011 | 277 | 2011 |
| Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer F Rothé, JF Laes, D Lambrechts, D Smeets, D Vincent, M Maetens, ... Annals of oncology 25 (10), 1959-1965, 2014 | 270 | 2014 |
| Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis FC Bidard, S Michiels, S Riethdorf, V Mueller, LJ Esserman, A Lucci, ... JNCI: Journal of the National Cancer Institute 110 (6), 560-567, 2018 | 269 | 2018 |
| Immune evasion before tumour invasion in early lung squamous carcinogenesis C Mascaux, M Angelova, A Vasaturo, J Beane, K Hijazi, G Anthoine, ... Nature 571 (7766), 570-575, 2019 | 260 | 2019 |
| DNA methylation profiling reveals a predominant immune component in breast cancers S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ... EMBO molecular medicine 3 (12), 726-741, 2011 | 238 | 2011 |
| HER2-positive circulating tumor cells in breast cancer M Ignatiadis, F Rothe, C Chaboteaux, V Durbecq, G Rouas, C Criscitiello, ... PloS one 6 (1), e15624, 2011 | 224 | 2011 |
| Principles governing A-to-I RNA editing in the breast cancer transcriptome D Fumagalli, D Gacquer, F Rothé, A Lefort, F Libert, D Brown, ... Cell reports 13 (2), 277-289, 2015 | 212 | 2015 |
| Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer FW Hunter, HR Barker, B Lipert, F Rothé, G Gebhart, MJ Piccart-Gebhart, ... British journal of cancer 122 (5), 603-612, 2020 | 209 | 2020 |
| Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting DJE Peeters, B De Laere, GG Van den Eynden, SJ Van Laere, F Rothé, ... British journal of cancer 108 (6), 1358-1367, 2013 | 182 | 2013 |
| Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations D Brown, D Smeets, B Székely, D Larsimont, AM Szász, PY Adnet, ... Nature communications 8 (1), 14944, 2017 | 170 | 2017 |
| Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach Y Bareche, L Buisseret, T Gruosso, E Girard, D Venet, F Dupont, ... JNCI: Journal of the National Cancer Institute 112 (7), 708-719, 2020 | 149 | 2020 |
| RNA sequencing to predict response to neoadjuvant anti-HER2 therapy: a secondary analysis of the NeoALTTO randomized clinical trial D Fumagalli, D Venet, M Ignatiadis, HA Azim, M Maetens, F Rothé, ... JAMA oncology 3 (2), 227-234, 2017 | 136 | 2017 |
| Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer L Buisseret, C Desmedt, S Garaud, M Fornili, X Wang, G Van den Eyden, ... Modern Pathology 30 (9), 1204-1212, 2017 | 113 | 2017 |
| Immune infiltration in invasive lobular breast cancer C Desmedt, R Salgado, M Fornili, G Pruneri, G Van den Eynden, ... JNCI: Journal of the National Cancer Institute 110 (7), 768-776, 2018 | 112 | 2018 |
| Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer A Hamm, H Prenen, W Van Delm, M Di Matteo, M Wenes, E Delamarre, ... Gut 65 (6), 990-1000, 2016 | 104 | 2016 |
| Circulating tumor DNA in HER2-amplified breast cancer: a translational research substudy of the NeoALTTO phase III trial F Rothé, MJ Silva, D Venet, C Campbell, I Bradburry, G Rouas, ... Clinical cancer research 25 (12), 3581-3588, 2019 | 96 | 2019 |
